Global Hyoscyamine Market Insights, Forecast to 2028

Hyoscyamine is a chemical compound, a tropane alkaloid it is the levo-isomer to atropine. It is a secondary metabolite of some plants. Hyoscyamine is used to provide symptomatic relief to various gastrointestinal disorders including spasms, peptic ulcers, irritable bowel syndrome, pancreatitis, colic and cystitis. It has also been used to relieve some heart problems, control some of the symptoms of Parkinson's disease, as well as for control of respiratory secretions in end of life care.
Market Analysis and Insights: Global Hyoscyamine Market
Due to the COVID-19 pandemic, the global Hyoscyamine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Oral accounting for % of the Hyoscyamine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Hyoscyamine market size is valued at US$ million in 2021, while the US and Europe Hyoscyamine are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Hyoscyamine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Hyoscyamine include GlaxoSmithKline, Jasper Pharm, Gem Pharmaceuticals, Irza Pharm, Hoechst, Lahore Chemical and Pharmaceutical Works, Genera Pharmaceuticals, Chen-ho Pharmaceuticals and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Hyoscyamine Scope and Segment
Hyoscyamine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Hyoscyamine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Oral
Injection
Segment by Application
Hospital
Drug Store
By Company
GlaxoSmithKline
Jasper Pharm
Gem Pharmaceuticals
Irza Pharm
Hoechst
Lahore Chemical and Pharmaceutical Works
Genera Pharmaceuticals
Chen-ho Pharmaceuticals
Pfizer
Karo Pharma
Yung Shin Pharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE